ArticleBlood2025
Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2-mutated post-MPN AML.
Zhe Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleBlood2025
Zhe Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.